Media

Media

Recent News

  • Avivagen Announces Chief Executive Officer and Issuance of Third Quarter Results

    Ottawa, ON / TNW-Accesswire / September 7, 2017 / – Avivagen Inc. (TSXV:VIV, OTC Pink:CHEXF) (Avivagen or the Corporation), a corporation with a proven and commercially-ready, patent-protected product intended to replace the antibiotics added to livestock feeds as growth promoters, announces that, in view of the progress of the Corporation, the board of directors has …Read More

  • Avivagen Announces Scale Up of Commercial Roll Out for OxC-beta™ Livestock in the Philippines

    Ottawa, ON / TNW-Accesswire / August 16, 2017 / – Avivagen Inc. (TSXV:VIV, OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a corporation with a proven and commercially-ready, patent-protected product intended to replace the antibiotics added to livestock feeds as growth promoters, is pleased to announce that its partner in the Philippines, UNAHCO, has confirmed that it …Read More

  • Cesar Millan To Endorse Avivagen’s Companion Animal Health Product Vivimune Health Chews

    Ottawa, ON / July 10, 2017 – Avivagen Inc. (“Avivagen” or the “Corporation” | TSXV: VIV, OTC Pink: CHEXF), a life sciences innovation company with a series of patent protected products that support and optimize health, announces that the Corporation has entered into a marketing agreement with Cesar Millan, world-renowned dog behaviorist, best-selling author, and …Read More

  • Avivagen Retains Hybrid Financial Inc. for Investor Relations Activities

    Ottawa, ON / TNW-Accesswire / July 4, 2017 / – Avivagen Inc. (TSXV:VIV, OTC Pink:CHEXD) (“Avivagen” or the “Corporation”), a corporation with a proven and commercially-ready, patent-protected product intended to replace the antibiotics added to livestock feeds as growth promoters, announces that it has retained the services of Hybrid Financial Inc. for investor relations activities. …Read More

  • Avivagen Provides Business Updates

      Ottawa, ON / TNW-Accesswire / June 5, 2017 / – Avivagen Inc. (TSXV:VIV, OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a corporation with a proven and commercially-ready, patent-protected product intended to replace the antibiotics added to livestock feeds as growth promoters, announces business updates and an operational update from its Chairman and Interim CEO Kym …Read More

View All News Releases

Media Coverage

  • CEO Kym Anthony Interviewed by Uptick

    CEO Kym Anthony was interviewed by the penny stock news and trends podcast, Uptick Newswire.

    I think if people keep their eyes on the size of the prize, [they’ll see] the livestock market is in the billions of dollars; our share of that would be in the hundreds of millions if we roll out successfully. The human market is untouched. The companion animal market is also big. We’ve spent years proving it works; everyone agrees it works. Now is the time to roll it out commercially.

  • Alternative to Antibiotics for Livestock Feed

    Ottawa Citizen:

    Ottawa-based Avivagen has developed an alternative to the antibiotics farmers add to livestock to boost animal growth.

    And that’s not chicken feed.

  • Producer.com: Antibiotic Alternative No Easy Sell to Regulators

    The Canadian Food Inspection Agency says it is streamlining the process, but it has an obligation to do its due diligence

    An interesting position: that’s the place Avivagen president Cameron Groome says he is in with regard to Canadian registration for a new product.

  • Canada's livestock feed regulations are outdated

    The Western Producer: Canada Must Better Meet Demand for Health Products

    Plant a seed but don’t allow the plant to grow. Encourage innovation but don’t provide the climate in which it can flourish.


    Sounds perverse, doesn’t it?


    Yet it is happening in Canada because of outdated regulations governing new livestock feed additives.


View All Media Coverage